Immunogenicity, antibody persistence, and safety of the 60 μg hepatitis B vaccine in hemodialysis patients: a multicenter, randomized, double-blind, parallel-controlled trial.
about
Immunogenicity, antibody persistence, and safety of the 60 μg hepatitis B vaccine in hemodialysis patients: a multicenter, randomized, double-blind, parallel-controlled trial.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Immunogenicity, antibody persi ...... nd, parallel-controlled trial.
@en
Immunogenicity, antibody persi ...... nd, parallel-controlled trial.
@nl
type
label
Immunogenicity, antibody persi ...... nd, parallel-controlled trial.
@en
Immunogenicity, antibody persi ...... nd, parallel-controlled trial.
@nl
prefLabel
Immunogenicity, antibody persi ...... nd, parallel-controlled trial.
@en
Immunogenicity, antibody persi ...... nd, parallel-controlled trial.
@nl
P2093
P2860
P1476
Immunogenicity, antibody persi ...... nd, parallel-controlled trial.
@en
P2093
Chunxia Li
Guangming Liu
Linying Gao
Minghu Pan
Suping Wang
Xiaofeng Liang
Xiaohong Shi
P2860
P304
P356
10.1080/14760584.2017.1367667
P577
2017-08-21T00:00:00Z